59 Recruiting Studies Using Filgrastim
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Filgrastim
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
π Children's Hospital of Alabama β Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist βAddition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
π National Institutes of Health Clinical Center β Bethesda, Maryland
Sickle Cell Anemia
View Study & Checklist βNonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
π National Institutes of Health Clinical Center β Bethesda, Maryland
Sickle Cell Disease
View Study & Checklist βAdcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
π Lucile Packard Children's Hospital Stanford University β Palo Alto, California
Stage II Childhood Hodgkin Lymphoma
View Study & Checklist βLow-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
π M D Anderson Cancer Center β Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist βNonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
π National Institutes of Health Clinical Center β Bethesda, Maryland
Sickle Cell Disease
View Study & Checklist βIrinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
π Memorial Sloan Kettering Cancer Center β New York, New York
Sarcoma
View Study & Checklist βStudy of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
π Rady Children's Hospital-San Diego β San Diego, California
Acute Leukemia of Ambiguous Lineage in Relapse
View Study & Checklist βNon-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
π National Institutes of Health Clinical Center β Bethesda, Maryland
Sickle Cell Disease
View Study & Checklist βA Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
π St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023) β Phoenix, Arizona
Metastatic Non-small Cell Lung Cancer
View Study & Checklist βImmunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
π Children's Hospital of Alabama β Birmingham, Alabama
Ann Arbor Stage III Hodgkin Lymphoma
View Study & Checklist βProtocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
π St. Jude Children's Research Hospital β Memphis, Tennessee
Retinoblastoma
View Study & Checklist βNivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
π Children's Hospital of Alabama β Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist βSorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
π M D Anderson Cancer Center β Houston, Texas
Recurrent Acute Myeloid Leukemia
View Study & Checklist βGenetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
π City of Hope Medical Center β Duarte, California
Recurrent Grade 1 Follicular Lymphoma
View Study & Checklist βCombination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
π Banner University Medical Center - Tucson β Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist βReduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
π Stanford University β Stanford, California
Allogeneic Hematopoietic Cell Transplantation (HCT)
View Study & Checklist βPediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
π Lucile Packard Children's Hospital Stanford University β Palo Alto, California
Hodgkin Lymphoma
View Study & Checklist βGene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
π NCI Lymphoid Malignancies Branch β Bethesda, Maryland
AIDS-Related Burkitt Lymphoma
View Study & Checklist βIbrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
π UC San Diego Moores Cancer Center β La Jolla, California
AIDS-Related Lymphoma
View Study & Checklist βCombination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
π Providence Hospital β Mobile, Alabama
Lung Adenocarcinoma
View Study & Checklist βVirotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
π National Institutes of Health Clinical Center β Bethesda, Maryland
Lymphoproliferative Disorder
View Study & Checklist βA Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
π Boston Children's Hospital β Boston, Massachusetts
Acute Myeloid Leukemia
View Study & Checklist βAllogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma
π University of California Davis Comprehensive Cancer Center β Sacramento, California
Recurrent Multiple Myeloma
View Study & Checklist βNeoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
π Abramson Cancer Center at the University of Pennsylvania β Philadelphia, Pennsylvania
Gastric Adenocarcinoma
View Study & Checklist βPhase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
π UT MD Anderson β Houston, Texas
Myeloid Leukemia
View Study & Checklist βBase-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
π National Institutes of Health Clinical Center β Bethesda, Maryland
WHIM
View Study & Checklist βAutologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
π Ohio State University Comprehensive Cancer Center β Columbus, Ohio
Locally Advanced Gastrointestinal Stromal Tumor
View Study & Checklist βStem Cell Mobilization and Apheresis for Life-threatening Blood Disorders
π Saint Jude Children's Research Hospital β Memphis, Tennessee
Bone Marrow Failure Syndrome
View Study & Checklist βTCRΞ±Ξ²-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naΓ―ve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
π St. Jude Children's Research Hospital β Memphis, Tennessee
Hematologic Malignancy
View Study & Checklist βChemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Acute Myeloid Leukemia
View Study & Checklist βThe Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
π City of Hope β Duarte, California
Peripheral Blood Stem Cell Transplantation
View Study & Checklist βTrial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
π Chao Family Comprehensive Cancer Center University of California, Irvine β Orange, California
Soft-tissue Sarcoma
View Study & Checklist βVenetoclax to Augment Epigenetic Modification and Chemotherapy
π Children's Wisconsin β Milwaukee, Wisconsin
Acute Myeloid Leukemia, in Relapse
View Study & Checklist βEtoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist βAccelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
π Memorial Sloan Kettering Cancer Centre β New York, New York
Germ Cell Tumor
View Study & Checklist βA Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
π Children's Hospital of Alabama β Birmingham, Alabama
Acute Myeloid Leukemia Post Cytotoxic Therapy
View Study & Checklist βMolecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
π Lucille Packard Children's Hospital Stanford β Palo Alto, California
Medulloblastoma
View Study & Checklist βHematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
π National Institutes of Health Clinical Center β Bethesda, Maryland
Idiopathic CD4-Positive
View Study & Checklist βStem Cell Transplantation in Crohn's Disease
π Cedars-Sinai Medical Center β Los Angeles, California
Crohn Disease
View Study & Checklist βRuxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
π City of Hope Medical Center β Duarte, California
Follicular Helper T-Cell Lymphoma
View Study & Checklist βFludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
π M D Anderson Cancer Center β Houston, Texas
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
View Study & Checklist βA Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
π Children's Hospital of Alabama β Birmingham, Alabama
Central Nervous System Nongerminomatous Germ Cell Tumor
View Study & Checklist βPhase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
π Boston Children's Hospital β Boston, Massachusetts
Sarcoma
View Study & Checklist βImproving White Blood Cell Collection From Healthy Donors
π National Institutes of Health Clinical Center β Bethesda, Maryland
Allogeneic Granulocyte Donation
View Study & Checklist βHaploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
π St Jude Children's Research Hospital β Memphis, Tennessee
Sickle Cell Disease
View Study & Checklist βDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Acute Leukemia
View Study & Checklist βPilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
π Alberta Children's Hospital β Calgary, Alberta
CNS Embryonal Tumor
View Study & Checklist βFilgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
π Gift of Life Bone Marrow Foundation β Boca Raton, Florida
Healthy
View Study & Checklist βBase Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
π National Institutes of Health Clinical Center β Bethesda, Maryland
Chronic Granulomatous Disease (CGD)
View Study & Checklist βTreatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
π Stanford University β Palo Alto, California
Rhabdomyosarcoma
View Study & Checklist βhSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
π University Hospitals Cleveland Medical Center β Cleveland, Ohio
Glioblastoma Multiforme
View Study & Checklist βCLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Recurrent Acute Myeloid Leukemia
View Study & Checklist βBendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
π M D Anderson Cancer Center β Houston, Texas
Hematopoietic and Lymphoid System Neoplasm
View Study & Checklist βDose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist βVenetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
π M D Anderson Cancer Center β Houston, Texas
High Risk Myelodysplastic Syndrome
View Study & Checklist βCD45RA-depleted CD19-CAR T Cell Consolidation After TCRΞ±Ξ²+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
π St. Jude Children's Research Hospital β Memphis, Tennessee
Relapsed Pediatric ALL
View Study & Checklist βMethylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
π M D Anderson Cancer Center β Houston, Texas
Aplastic Anemia
View Study & Checklist βPhase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
π National Institutes of Health Clinical Center β Bethesda, Maryland
Hematologic Neoplasms
View Study & Checklist β